Usefulness and safety of treatment with captopril in posttransplant erythrocytosis.
Hernández
E
E
Nephrology Department, Hospital 12 de Octubre, Madrid, Spain.
Morales
J M
JM
Andrés
A
A
Ortuño
B
B
Praga
M
M
Alcazar
J M
JM
Fernández
G
G
Rodicio
J L
JL
D002216:Captopril / Q000009:adverse effects / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D004921:Erythropoietin / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006400:Hematocrit; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D009543:Nifedipine / Q000627:therapeutic use*; D011086:Polycythemia / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications / Q000188:drug therapy*; D011188:Potassium / Q000097:blood; D013997:Time Factors
D006454:Hemoglobins; D004921:Erythropoietin; D002216:Captopril; D003404:Creatinine; D009543:Nifedipine; D011188:Potassium